Amrita institute of Medical Sciences

Kochi, Kerala 682041

5 studies enrolling now · 13 studies all time

What they study most

Adenocarcinoma of the Esophagus, Anemia, CPSS (Congenital Portosystemic Shunt), Congenital Portosystemic Shunt, Esophageal Cancer, Heart Failure, Kidney Neoplasms, Lupus Erythematosus, Systemic, Lupus Nephritis, Moderately to Severely Active Crohns Disease, Myelofibrosis, Obesity

Studies at this site

• A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• International Registry of Congenital Portosystemic Shunt (IRCPSS) — Enrolling by invitation
• Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity — Completed
• Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer — Stopped early
• Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms — Stopped early
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis — Completed
• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin — Completed
• Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early